Home / Inspections / 1166014

FDA Inspection 1166014 — Holy Cross of Silver Spring Blood Bank

Holy Cross of Silver Spring Blood Bank — FEI 1173166

The FDA completed an inspection of Holy Cross of Silver Spring Blood Bank on February 28, 2022 in Silver Spring, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 28, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Silver Spring, MD (United States)

Facility

Other inspections at this facility

  • 1253461 (NAI Tue Oct 22 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1081239 (NAI Tue Jan 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1014489 (NAI Thu May 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 910320 (NAI Tue Jan 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 836133 (NAI Tue Jun 04 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources